Compare EVAX & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVAX | ATCH |
|---|---|---|
| Founded | 2008 | 2022 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.7M | 39.9M |
| IPO Year | 2021 | N/A |
| Metric | EVAX | ATCH |
|---|---|---|
| Price | $5.85 | $0.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.33 | N/A |
| AVG Volume (30 Days) | 98.3K | ★ 4.3M |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,650,000.00 | ★ $12,303,120.00 |
| Revenue This Year | $128.77 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 132.17 | 80.78 |
| 52 Week Low | $1.20 | $0.14 |
| 52 Week High | $12.15 | $15.27 |
| Indicator | EVAX | ATCH |
|---|---|---|
| Relative Strength Index (RSI) | 52.12 | 41.82 |
| Support Level | $5.72 | $0.29 |
| Resistance Level | $6.70 | $0.31 |
| Average True Range (ATR) | 0.47 | 0.03 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 50.26 | 8.69 |
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.